Application
Formalin-fixed and paraffin-embedded human hepatocarcinoma tissue reacted with TYRO3 Antibody (Cat.#AM7679b), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.
Application
Confocal immunofluorescent analysis of TYRO3 Antibody (Cat#AM7679b) with HepG2 cell followed by Alexa Fluor 488-conjugated goat anti-mouse lgG (green). DAPI was used to stain the cell nuclear (blue).
IHC
(H) IHC staining of TYRO3 in patients with lung cancer who received anti–PD-1/PD-L1 therapy. H score for TYRO3 expression in patients who were resistant or nonresistant to anti–PD-1/PD-L1 therapy. n = 12 resistant patients; n = 17 nonresistant patients. *P = 0.0132, by 2-tailed, unpaired Student’s t test. Scale bars: 50 μm (left) and 25 μm (right). Data are presented as the mean ± SD.